Chemomab Therapeutics Ltd DRC
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,279 | -1,832 | -1,968 | -1,830 |
EBIT | -2,241 | -1,850 | -1,986 | -1,844 |
Net Income | -2,202 | -1,773 | -1,884 | -1,742 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,221 | |||
Cash | 5,998 | 5,906 | 7,563 | 6,974 |
Basic Shares | 8,003 | 7,978 | 7,821 | 6,179 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -70 | -53 | -66 | -57 |
EBITDA | -9,497 | -14,686 | -25,392 | -28,475 |
EBIT | -9,567 | -14,739 | -25,459 | -28,532 |
Net Income | -8,995 | -13,945 | -24,221 | -27,646 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,221 | -15,459 | -23,553 | -20,358 |
Cash | 7,563 | 6,071 | 9,292 | 13,519 |
Basic Shares | 6,377 | 202 | 2,937 | 2,844 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$1.40 |
2026-06-30 | -$1.40 |
2026-03-31 | -$0.003 |
2025-12-31 | -$0.003 |